Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

News and Opinion from the Pandemic Sciences Institute at the Nuffield Department of Medicine, University of Oxford

Oxford hosts Belgian vaccine experts

News Vaccines, treatments, diagnostics & trials

Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.

Speaker line-up announced for the International Pandemic Sciences Conference 2024

Events News

Meet the presenters, panellists and chairs for the International Pandemic Sciences Conference 2024, set to take place on 1–2 July 2024 in Oxford and online.

New Pandemic PACT research programme launched

Ethics, social science & humanities Research news

The Pandemic Sciences Institute, in collaboration with the global coalition of health research funders GloPID-R and UKCDR, has launched a new research programme including an interactive platform to track and analyse over $7 billion in global pandemic research funding.

Study reveals high number of persistent COVID-19 infections in the general population

Epidemiology & data Research news

A new study – led by researchers at PSI – has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published today in the journal Nature.

Abstract submission deadline extended: International Pandemic Sciences Conference 2024

Events News

The deadline for abstract submissions and bursary applications for the International Pandemic Sciences Conference 2024 – Collaboration Beyond Boundaries has been extended to Monday 26 February 2024.

Students explore 'wicked problem' of pandemics


Students on the MSc International Health and Tropical Medicine programme discussed pandemics, during a day exploring some of the major challenges in global health, hosted by PSI's Dr Alice Norton.

New teaching collaboration with Brazilian universities

Partner news

The University of Oxford has entered into an agreement with three Brazilian universities, to contribute to the delivery of an undergraduate course in ‘Translational Science’, starting in 2024. The course will teach the full journey of a product ‘from bench to bedside’ as part of any science degree to prepare the next generation of researchers for the translation of their laboratory discoveries into patient care and prevention.

FCDO Minister meets with University of Oxford’s vaccine researchers

Partner news Vaccines, treatments, diagnostics & trials

The University of Oxford this week welcomed the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.

Registration open for International Pandemic Sciences Conference 2024

Events News

PSI set to host international scientific conference in Oxford and online this July, to foster global research collaboration and prepare world for future pandemics.

Public health vision led by researchers from Oxford and Bangladesh aims to tackle Nipah virus

Nipah virus Partner news

In a new paper published in The Lancet Infectious Diseases, researchers based in Bangladesh, Oxford and Geneva call for a comprehensive public health framework to counter Nipah virus and other neglected infectious diseases with pandemic potential.

Vaccine trial for deadly Nipah virus launched

Nipah virus Research news Vaccines, treatments, diagnostics & trials

Oxford-led UK trial is first step to developing a vaccine against Nipah virus – a devastating disease mostly found in South-East Asia.

New partnership aims to advance vaccine against MERS coronavirus

Partner news Vaccines, treatments, diagnostics & trials

A partnership between CEPI, Barinthus Biotherapeutics and the University of Oxford aims to fast-track the development of a potential vaccine for the prevention of Middle East Respiratory Syndrome (MERS).

Study reveals that duration of exposure to COVID-19 plays major role in risk of catching the virus

Epidemiology & data Research news

Using data from 7 million people notified by the NHS COVID-19 contact tracing app, this is the first large-scale study to reveal how duration and proximity of contact with an infected person affects how COVID-19 is spread.

Nipah virus: How a neglected disease raises new ethical questions

Ethics, social science & humanities Nipah virus Research news

New University of Oxford research brings to light important ethical considerations in Nipah virus outbreak control, its treatment, and research into vaccines.

Funders Roadmap is supporting better clinical trials

Ethics, social science & humanities Research news

New framework helps funders to support coordinated, effective and equitable clinical trials in response to epidemics and pandemics.

Oxford receives £7.8 million to develop vaccines to fight epidemic and pandemic threats

Partner news Vaccines, treatments, diagnostics & trials

New funding will support research into the prevention of five dangerous diseases with epidemic and pandemic potential.

Call for applications to establish networks of epidemic and pandemic sciences research excellence across Africa

Partner news Research news

PSI has joined forces with the Science for Africa Foundation and the Mastercard Foundation to launch a call for applications to establish innovative networks of research excellence in epidemic and pandemic sciences across Africa.

Oxford welcomes global pandemic experts for focus on 100 Days Mission

Partner news Vaccines, treatments, diagnostics & trials

Scientific advisors to the International Pandemic Preparedness Secretariat (IPPS) visited the University of Oxford’s vaccine laboratories as part of a two-day meeting of the global coalition.

CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses

Research news Vaccines, treatments, diagnostics & trials

CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Junín virus, with a new project led by Professor Teresa Lambe.

World-leading RECOVERY trial expands to investigate treatments for influenza

Research news

The RECOVERY trial, the leading global clinical trial of treatments for COVID-19, has expanded to find effective treatments for patients hospitalised with flu.

Load More